Based in Tel Aviv, Datos Health stands out among health-related startups in Israel and around the globe. Unlike other Patient-Generated Health Data (PGHD) management solutions, Datos extracts the value from the tsunami of raw patient big data and automates care processes, delivering remote care at a fraction of the current cost.
Photo Credit: Datos Health
Datos Health helps health care organizations, case managers, doctors and patients better manage PGHD on a large scale.
The Israeli PGHD management platform automatically collects, manages and verifies the data emitted by any wearable medical monitoring device, such as a digital blood pressure monitor or blood glucose monitor (glucometer), and at-home health monitoring devices. Datos’ technology then seamlessly incorporates only the reliable data and derived patient insights directly into the doctors’ everyday clinical workflow with no additional effort.
Care teams can now continuously manage a patients’ complete digital health footprint for enhanced clinical decision support and early intervention to avert the onset of serious and costly care episodes. Patients can also receive improved care without ever having to leave their home.
Unlike other PGHD management platforms, Datos Health analyzes and extracts only the reliable medical data to place into clinical context within the existing workflow. For care teams, this provides a trusted view of each patient’s total digital health picture.
Datos Health CEO Uri Bettesh told JerusalemOnline that the Datos proprietary Big Data technology collects data from medical-grade devices and wearable consumer devices. Relying on data from just the consumer can be misleading to a doctor.
Watch: How Datos is helping health care organizations
“By combining the different quality data streams, we strengthen the accuracy of the complete patient information,” he said. “For example, by correlating the trends from a consumer activity tracker with a reliable blood pressure reading, our algorithms notice that a patient walked prior to taking a blood pressure reading. When placed into context, the latter measurement is now unreliable.”
Bettesh stressed that without a holistic patient view from all devices, the data that we may think is accurate from high-quality devices may actually be misleading the doctor. “To enhance remote data-recording reliability, our technology simulates the way measurements are taken in a clinical setting at home,” he added.
Seven pilot programs, within different population groups, monitoring hypertension, diabetes, elderly care and high-risk pregnancies are being conducted concurrently in the U.S., South Africa and Israel.
Datos Health recently announced the signing of a go-to-market (GTM) agreement with U.S.-based Strategic Interests, LLC (SI). According to the press release, this partnership will “expedite entry of Datos’ proprietary remote patient management solution within the U.S. healthcare market.”
With the help of SI, Datos has launched two pilot programs in the U.S. Its first pilot with Ridgeview Internal Medicine Group, LLP in Rochester, New York, is helping physicians and care managers monitor patients with hypertension “by using the Datos platform to provide clean, validated PGHD and derived insights directly into their existing electronic medical record (EMR).”
“The Datos pilot will enable us to electronically initiate our existing care plans, helping our care team save time, improve quality measures and more actively manage a larger proportion of our patients who suffer from chronic conditions,” stated Joseph A. DiPoala, Jr., MD, from Ridgeview Internal Medical Group.
Ridgeview plans to extend Datos’ monitoring capabilities to other chronic health conditions.